BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang WJ, He WY, Li JD, He RQ, Huang ZG, Zhou XG, Li JJ, Zeng DT, Chen JT, Wu WZ, Dang YW, Chen G. Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues. Bioengineered 2021;12:4054-69. [PMID: 34369278 DOI: 10.1080/21655979.2021.1952791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Qin LT, Huang SW, Huang ZG, Dang YW, Fang YY, He J, Niu YT, Lin CX, Wu JY, Wei ZX. Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma. BMC Med Genomics 2022;15:272. [PMID: 36577966 DOI: 10.1186/s12920-022-01412-8] [Reference Citation Analysis]
2 Fang Y, Huang J, Wen J, Li J, Shen J, Zeng D, Pan Y, Huang H, Huang Z, Liu L, Chen G. AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer. PGPM 2022;Volume 15:999-1017. [DOI: 10.2147/pgpm.s360147] [Reference Citation Analysis]
3 Gao L, Chen G, Liang ZQ, Li JD, Li DM, Tang YL, Tang D, Huang ZG, Chen JH, Luo JY, Zeng JH, Dang YW, Feng ZB. Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods. Pathol Oncol Res 2022;28:1610307. [PMID: 35693634 DOI: 10.3389/pore.2022.1610307] [Reference Citation Analysis]
4 Wang L, Ding Y, Zhang C, Chen R. Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients. PLoS ONE 2022;17:e0269249. [DOI: 10.1371/journal.pone.0269249] [Reference Citation Analysis]
5 Vastrad B, Vastrad C. Bioinformatics analysis of differentially expressed genes in non alcoholic fatty liver disease using next generation sequencing data.. [DOI: 10.1101/2021.12.16.472893] [Reference Citation Analysis]